Gelişmiş Arama

Basit öğe kaydını göster

dc.contributor.authorErtürk, Aliye Gediz
dc.contributor.authorŞahin, Arzu
dc.contributor.authorAy, Ebru Batı
dc.contributor.authorPelit, Emel
dc.contributor.authorBağdatlı, Emine
dc.contributor.authorKulu, İrem
dc.contributor.authorYıldırım, Tuba
dc.date.accessioned2021-12-12T17:02:15Z
dc.date.available2021-12-12T17:02:15Z
dc.date.issued2021
dc.identifier.issn1420-3049
dc.identifier.urihttps://doi.org/10.3390/molecules26123526
dc.identifier.urihttps://hdl.handle.net/20.500.11857/3417
dc.description.abstractSince December 2019, humanity has faced an important global threat. Many studies have been published on the origin, structure, and mechanism of action of the SARS-CoV-2 virus and the treatment of its disease. The priority of scientists all over the world has been to direct their time to research this subject. In this review, we highlight chemical studies and therapeutic approaches to overcome COVID-19 with seven different sections. These sections are the structure and mechanism of action of SARS-CoV-2, immunotherapy and vaccine, computer-aided drug design, repurposing therapeutics for COVID-19, synthesis of new molecular structures against COVID-19, food safety/security and functional food components, and potential natural products against COVID-19. In this work, we aimed to screen all the newly synthesized compounds, repurposing chemicals covering antiviral, anti-inflammatory, antibacterial, antiparasitic, anticancer, antipsychotic, and antihistamine compounds against COVID-19. We also highlight computer-aided approaches to develop an anti-COVID-19 molecule. We explain that some phytochemicals and dietary supplements have been identified as antiviral bioproducts, which have almost been successfully tested against COVID-19. In addition, we present immunotherapy types, targets, immunotherapy and inflammation/mutations of the virus, immune response, and vaccine issues.en_US
dc.language.isoengen_US
dc.publisherMdpien_US
dc.relation.ispartofMoleculesen_US
dc.identifier.doi10.3390/molecules26123526
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectSARS-CoV-2en_US
dc.subjectCOVID-19en_US
dc.subjectcytokine stormen_US
dc.subjectimmunotherapyen_US
dc.subjectvaccine developmenten_US
dc.subjectin-silico researchen_US
dc.subjectsmall drugsen_US
dc.subjectrepurposing drugsen_US
dc.subjectdietary supplementsen_US
dc.subjectnatural productsen_US
dc.titleA Multidisciplinary Approach to Coronavirus Disease (COVID-19)en_US
dc.typereview
dc.authoridEryilmaz, Serpil/0000-0002-0935-4644
dc.departmentFakülteler, Fen-Edebiyat Fakültesi, Kimya Bölümü
dc.identifier.volume26en_US
dc.identifier.issue12en_US
dc.relation.publicationcategoryDiğeren_US
dc.authorscopusid42461181600
dc.authorscopusid57216556997
dc.authorscopusid57204799925
dc.authorscopusid16203801600
dc.authorscopusid8311588700
dc.authorscopusid26666132300
dc.authorscopusid23978054400
dc.identifier.wosWOS:000666658300001en_US
dc.identifier.scopus2-s2.0-85110356244en_US
dc.identifier.pmidPubMed: 34207756en_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster